| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76ba102ea9c02b6633d64bf09c5b89a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcce39a20bef16c3f04497659caba40f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00 |
| filingDate |
2013-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5bc58545e4430567941d6b596cc3d44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad41503dcbc2e9684e3c883097fd04e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c6de1555ecd0587878b49c02e93004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f0539a490e19fddb6da9bb80d3ce6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e4ed990632221933f224cbffe18e69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc144286076394250cc6c4fe454e2b39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb0f14c57a1bef338280b16406a67cbe |
| publicationDate |
2014-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201420113-A |
| titleOfInvention |
Prevention of kidney damage or disease |
| abstract |
The present invention relates to a dosing regimen of an alpha-melanocyte stimulating hormone ([alpha]-MSH) peptide analog that has an enhanced potency against a native alpha-MSH peptide for the treatment or prevention of kidney damage or disease. |
| priorityDate |
2012-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |